High Dose Immunoglobulin (IVIG) May Reduce the Incidence of Langerhans Cell Histiocytosis (LCH)-Associated Central Nervous System Involvement

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 5, 2009-01 ,pp. : 380-386

Bentham Science Publishers

Access to resources Recommend Favorite

Drug therapy for the treatment of Langerhans cell histiocytosis

By McClain Kenneth L  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2435-2441

Informa Healthcare

Access to resources Recommend Favorite

Patients with common variable immunodeficiency (CVID) requiring IV immunoglobulin (IVIG) therapy have poorer health-related (HR) QOL than individuals with other chronic diseases

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 461, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Serum Trough IgG level and Annual Intravenous Immunoglobulin Dose Are Not Related to Body Size in Patients on Regular Replacement Therapy

By  

Drug Metabolism Letters, Vol. 5, Iss. 2, 2011-04 ,pp. : 132-136

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy

By Ahmed A Razzaque  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 8, 2004-08 ,pp. : 1019-1032

Informa Healthcare

Access to resources Recommend Favorite